1. Kim, Hyeon Ji, Kim, DO-Yeon. . Potential Anti-tumor Properties of PDIA4 in Lung Adenocarcinoma. In Anticancer research, 44, 4309-4315. doi:10.21873/anticanres.17260. https://pubmed.ncbi.nlm.nih.gov/39348977/
2. Xing, Feng, Song, Zhijiao, Cheng, Zhongping. 2022. High expression of PDIA4 promotes malignant cell behavior and predicts reduced survival in cervical cancer. In Oncology reports, 48, . doi:10.3892/or.2022.8399. https://pubmed.ncbi.nlm.nih.gov/36082822/
3. Shen, Yue, Zhang, Nasha, Chai, Jie, Han, Linyu, Yang, Ming. . CircPDIA4 Induces Gastric Cancer Progression by Promoting ERK1/2 Activation and Enhancing Biogenesis of Oncogenic circRNAs. In Cancer research, 83, 538-552. doi:10.1158/0008-5472.CAN-22-1923. https://pubmed.ncbi.nlm.nih.gov/36562654/
4. Li, Haoyu, Liu, Qing, Xiao, Kai, Ma, Qianquan, Su, Jun. 2021. PDIA4 Correlates with Poor Prognosis and is a Potential Biomarker in Glioma. In OncoTargets and therapy, 14, 125-138. doi:10.2147/OTT.S287931. https://pubmed.ncbi.nlm.nih.gov/33447054/
5. Jiang, Xiao, Li, Caiyun, Xia, Xuting, Cheng, Jin, Li, Xinhui. 2023. Exploring the Common Gene Signatures Between Myocardial Infarction-Reperfusion Injury and the Gut Microbiome Using Bioinformatics. In The heart surgery forum, 26, E498-E511. doi:10.59958/hsf.5775. https://pubmed.ncbi.nlm.nih.gov/37920088/
6. Yin, Fuqiang, Yi, Shang, Wei, Luwei, Dong, Caihua, Liu, Xia. 2018. Microarray-based identification of genes associated with prognosis and drug resistance in ovarian cancer. In Journal of cellular biochemistry, 120, 6057-6070. doi:10.1002/jcb.27892. https://pubmed.ncbi.nlm.nih.gov/30335894/
7. Kisling, Sophia G, Atri, Pranita, Shah, Ashu, Ghersi, Dario, Batra, Surinder K. . A Novel HOXA10-Associated 5-Gene-Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Ductal Adenocarcinoma. In Clinical cancer research : an official journal of the American Association for Cancer Research, 29, 3759-3770. doi:10.1158/1078-0432.CCR-23-0825. https://pubmed.ncbi.nlm.nih.gov/37432996/
智鼠故事 
